Company intelligence / Profile preview

IPERION

Vlijmen, North Brabant, Netherlands

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Iperion is a leading global life sciences consultancy specializing in Regulatory Information Management (RIM) and the implementation of ISO IDMP (Identification of Medicinal Products) standards. Acquired by Deloitte in 2021, the company provides advisory and managed services to pharmaceutical companies and regulatory agencies to digitize and standardize medicinal product data. Their expertise focuses on improving data interoperability, ensuring regulatory compliance, and accelerating the approval process for new medicines. Iperion is recognized for its role in shaping digital healthcare through standardized data exchange and advanced analytics tools like DocQMiner.

Industry: Consulting

Partnerships

European Medicines Agency (EMA)U.S. Food and Drug Administration (FDA)GenerisEdenlab

Beyond the preview

Go deeper on IPERION.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPERION.

Explore the full profile